Vera Therapeutics (VERA) Competitors $22.10 -0.52 (-2.30%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$22.35 +0.25 (+1.13%) As of 06:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERA vs. ROIV, RVMD, VRNA, BBIO, ELAN, GRFS, TLX, TGTX, NUVL, and LEGNShould you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include Roivant Sciences (ROIV), Revolution Medicines (RVMD), Verona Pharma (VRNA), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Grifols (GRFS), Telix Pharmaceuticals Limited American Depositary Shares (TLX), TG Therapeutics (TGTX), Nuvalent (NUVL), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. Vera Therapeutics vs. Its Competitors Roivant Sciences Revolution Medicines Verona Pharma BridgeBio Pharma Elanco Animal Health Grifols Telix Pharmaceuticals Limited American Depositary Shares TG Therapeutics Nuvalent Legend Biotech Vera Therapeutics (NASDAQ:VERA) and Roivant Sciences (NASDAQ:ROIV) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment. Does the media prefer VERA or ROIV? In the previous week, Vera Therapeutics had 9 more articles in the media than Roivant Sciences. MarketBeat recorded 22 mentions for Vera Therapeutics and 13 mentions for Roivant Sciences. Roivant Sciences' average media sentiment score of 0.71 beat Vera Therapeutics' score of 0.60 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is VERA or ROIV more profitable? Vera Therapeutics has a net margin of 0.00% compared to Roivant Sciences' net margin of -119.54%. Roivant Sciences' return on equity of -14.05% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -50.13% -39.50% Roivant Sciences -119.54%-14.05%-12.81% Do analysts rate VERA or ROIV? Vera Therapeutics currently has a consensus price target of $65.00, indicating a potential upside of 194.12%. Roivant Sciences has a consensus price target of $17.50, indicating a potential upside of 55.14%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Vera Therapeutics is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.10Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, VERA or ROIV? Vera Therapeutics has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Do insiders & institutionals have more ownership in VERA or ROIV? 99.2% of Vera Therapeutics shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 16.3% of Vera Therapeutics shares are held by company insiders. Comparatively, 7.9% of Roivant Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in VERA or ROIV? Roivant Sciences received 9 more outperform votes than Vera Therapeutics when rated by MarketBeat users. Likewise, 78.87% of users gave Roivant Sciences an outperform vote while only 68.12% of users gave Vera Therapeutics an outperform vote. CompanyUnderperformOutperformVera TherapeuticsOutperform Votes4768.12% Underperform Votes2231.88% Roivant SciencesOutperform Votes5678.87% Underperform Votes1521.13% Which has stronger valuation & earnings, VERA or ROIV? Roivant Sciences has higher revenue and earnings than Vera Therapeutics. Roivant Sciences is trading at a lower price-to-earnings ratio than Vera Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$95.99M-$3.00-7.37Roivant Sciences$29.05M263.94$4.35B-$0.25-45.12 SummaryVera Therapeutics and Roivant Sciences tied by winning 9 of the 18 factors compared between the two stocks. Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERA vs. The Competition Export to ExcelMetricVera TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.41B$6.85B$5.57B$8.62BDividend YieldN/A2.56%5.28%4.18%P/E Ratio-8.478.7827.1120.06Price / SalesN/A255.64409.88157.10Price / CashN/A65.8538.2534.64Price / Book11.396.557.064.70Net Income-$95.99M$143.93M$3.23B$247.88M7 Day Performance-27.85%3.97%2.88%2.66%1 Month Performance-1.73%11.32%9.04%6.40%1 Year Performance-41.84%4.20%31.40%14.07% Vera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERAVera Therapeutics2.8949 of 5 stars$22.10-2.3%$65.00+194.1%-42.5%$1.41BN/A-8.4740Short Interest ↑Analyst RevisionROIVRoivant Sciences2.3781 of 5 stars$11.17+1.6%$17.50+56.7%+6.7%$7.97B$29.05M-74.46860RVMDRevolution Medicines4.4448 of 5 stars$40.65+3.2%$67.08+65.0%+4.5%$7.57B$742K-11.32250Positive NewsVRNAVerona Pharma2.3658 of 5 stars$84.10+3.6%$82.13-2.3%+573.5%$6.82B$118.54M-43.8030Trending NewsAnalyst ForecastAnalyst RevisionBBIOBridgeBio Pharma4.6239 of 5 stars$35.46+3.5%$57.09+61.0%+42.1%$6.73B$127.42M-12.44400Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionELANElanco Animal Health1.1137 of 5 stars$13.440.0%$15.17+12.9%-22.3%$6.67B$4.43B33.599,800Positive NewsGRFSGrifols3.6544 of 5 stars$8.30-0.1%N/A+28.4%$5.71B$7.21B7.0926,300TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.80-1.1%$22.00+31.0%N/A$5.68B$783.21M0.00N/APositive NewsTGTXTG Therapeutics2.9618 of 5 stars$35.75+1.8%$40.80+14.1%+137.3%$5.68B$386.39M-357.46290Positive NewsAnalyst RevisionNUVLNuvalent2.4074 of 5 stars$77.18+3.4%$115.50+49.7%-2.7%$5.54BN/A-22.2440Positive NewsLEGNLegend Biotech3.0745 of 5 stars$29.32+1.3%$76.20+159.9%-17.3%$5.39B$728.30M-30.861,070Trending NewsShort Interest ↑Analyst Revision Related Companies and Tools Related Companies Roivant Sciences Competitors Revolution Medicines Competitors Verona Pharma Competitors BridgeBio Pharma Competitors Elanco Animal Health Competitors Grifols Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors TG Therapeutics Competitors Nuvalent Competitors Legend Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
